Industry Trends
Explore long-term trends shaping the global cannabis economy, from legalisation to innovation.
Industry Trends · page 4
- Clinical Research
Cannabis Rescheduling is Here: Trump Signs Executive Order to Move Cannabis to Schedule III
After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive order (EO) to push cannabis rescheduling through on Thursday (December 18).
- Industry Trends
Could Trump Actually Reschedule Cannabis This Time?
Cannabis Rescheduling fervour has once again reached dramatic levels following media reports that President Donald Trump is considering pushing through the long-touted move via an executive order.
- Industry Trends
In the UK’s Medical Cannabis Market, the Winner Takes All
Earlier this week, we looked at the dramatic shifts in the UK medical cannabis flower market over the last three years.
- Industry Trends
Germany’s Hidden Stigma Crisis: Why Pillar 2 is Still Sorely Needed
By: Dr. Sebastián Marincolo, Director of Strategic Content & Editorial, Weed.de Germany’s partial cannabis legalisation was originally designed to undercut the black market.
- Industry Trends
What Is Really Going on in the UK’s Medical Cannabis Market? (New 2025 Data Analysis)
The UK’s medical cannabis industry has nearly tripled in size since 2022, according to new Freedom of Information data offering the most comprehensive look into what is being prescribed in the UK to date.
- Hemp Industry
Federal Agencies ‘May Lack Resources’ to Enforce US Hemp Ban, Congressional Researchers Warn
The incoming changes to hemp classification in the US are already facing major issues, with the Government’s own Congressional Research Service (CRS) stating that it remains ‘unclear’ how it will be enforced in practice.
- Industry Trends
First Practical Medical Cannabis Oil Dosing Guide Published for UK Clinicians
Originally published on Cannabis Health The Medical Cannabis Clinicians Society (MCCS) has published what it describes as a crucial step forward for standardised prescribing in the UK, a comprehensive guide establishing evidence-based dosing protocols for cannabis oils.
- CBD Market
Medicare CBD Coverage Proposed, But Federal Ban Threatens Entire Industry
Cannabis stocks enjoyed another spike last week following reports that the Centers for Medicare & Medicaid Services is preparing to authorise insurance coverage for CBD products under certain Medicare programs, even as the same products face an existential threat from recently passed federal legislation.
- Industry Trends
Kanabo Calls in Administrators, Marking Sobering End to LSE Cannabis Rush
UK medical cannabis operator Kanabo Group has fallen into administration, seeing the last remaining member of the first four cannabis pioneers onto the London Stock Exchange face collapse.
- Clinical Research
Ananda Exits Landmark NHS-Funded Epilepsy Trial and Public Markets
Ananda Pharma, one of the UK’s leading clinical-stage pharmaceutical cannabis companies, has announced a string of strategic pivots, including stepping away from a flagship UK clinical trial into epilepsy.
- Hemp Industry
UK Court Throws Out CBD Case Over Improper Testing, but Operators ‘More Vulnerable Than Ever’
A UK Crown Court has thrown out criminal charges against CBD hemp flower importers after ruling that police mishandled evidence and used improper testing methods, but only after a five-and-a-half-year ordeal that destroyed the defendants’ businesses and forced them to relocate abroad.
- Industry Trends
Bundesrat Backs Tighter Cannabis Prescribing Rules, Rejects Mail-Order Penalties
Germany’s Bundesrat voted on November 21 to support key restrictions on medical cannabis prescribing and distribution, while rejecting proposals to ban prescriptions being sent via mail, a mixed outcome that offers both relief and concern for an industry bracing for regulatory tightening.
